Category Patents/Designs/Trade Secrets

New Confidential Text Shows Draft Deal On UN Tuberculosis Declaration

A newly agreed draft text of the United Nations political declaration on tuberculosis was released to governments today, affirming the use of flexibilities in international trade rules on intellectual property, but excluding actionable language on those rules.

New Health Ministry Of Chile Reaffirms Path To Compulsory Licence For Hepatitis C Drugs

Last week, Chilean Health Minister Emilio Santelices, appointed by President Piñera - who took office this year - rejected an attempt from company Gilead and a Big Pharma-related association of international drug makers in Chile to put down the resolution 399/2018 declaring public health justifications for the issuing of compulsory licences for sofosbuvir to treat a hepatitis C epidemic in Chile, that was issued by the previous government of Michele Bachelet, writes Luis Villarroel.

WIPO Publishes Report On Its Workforce

The United Nations World Intellectual Property Organization has released statistics on its workforce showing that 118 countries are represented in WIPO staff, some 50 percent of which benefit from permanent contracts, while the organisation has become a strong magnet for job applicants, over 12,000 in 2017.

African Health Ministers Approve Roadmap For Medicines Access, Framework To End Cholera

Health ministers from the World Health Organization Africa region last week endorsed a roadmap for access for the years 2019-2023 concerning areas such as fair pricing, intellectual property management, and supply chain management. The previous day, they pledged to implement key strategies to end cholera outbreaks in the African region by 2030.

UN Tuberculosis Negotiations: What Is At Stake?

With negotiations over the final language of a United Nations high level declaration on ending tuberculosis still ongoing, the stakes are high as different TB stakeholders await the outcome. The language in question could either raise or reduce barriers to affordable access to life-saving TB drugs, according to civil society groups.

USTR: Mexico Agrees To Raise IP Enforcement Standards With The US

Mexico and the United States have reached a preliminary agreement to raise standards of enforcement of intellectual property rights, according to the Office of the US Trade Representative (USTR). Among the terms, the agreement appears to toughen requirements for internet service providers in protecting against copyright theft and extend copyright terms, and might make it harder for Mexico to agree elsewhere to strengthen its protection of geographical indications.

New Dutch Foundation To Address High Medicines Pricing Announces Plan To File Complaint With Competition Authority

The newly established Dutch Pharmaceutical Accountability Foundation has announced its first action to address unreasonably high medicines prices in the Netherlands. The Foundation will request the Netherlands Authority for Consumers and Markets to look into the price hike for the medicine chenodeoxycholic acid (CDCA) by the company Leadiant Biosciences Ltd (formerly Sigma-Tau). CDCA is used for the treatment of children and adults with cerebrotendinous xanthomatosis (CTX), a rare genetic metabolic disease that affects around 60 people in the Netherlands.

Negotiators On UN TB Resolution May Have A Deal

NEW YORK – Negotiators for a United Nations declaration on tuberculosis, meeting intensively in New York this week, may have reached agreement today on a key sticking point related to intellectual property, innovation and access to new medicines, according to sources. An agreement, if accepted by other delegations, could allow the text to proceed to the high-profile High-Level Meeting scheduled to take place at the UN General Assembly next month.

USPTO Seeks Comments On Draft Strategic Plan 2018-2022

The United States Patent and Trademark Office (USPTO) is seeking comments on its draft strategic plan for the years 2018-2022. The draft plan covers a range of goals, including optimizing patent and trademark quality and timeliness, and providing "domestic and global leadership to improve intellectual property policy, enforcement, and protection worldwide."